We are international
Donate
• about myeloma TEXT SIZE   


Spring 2014 Volume 9, Issue 10:
Myeloma Today Spring 2014
Volume 9 Number 10

Articles include:

  • SAR6500984:  A New "Blockbuster" Drug For Myeloma
  • Black Swan Research Initiative® (BSRI®) Debut of a Highly Sensitive MRD Test
  • Life is Good and Misery is Optional: A Conversation with Kenton Hofmeister

05.02.14
  • Dear Reader: 
    • A message from IMF President Susie Novis
  • Scientific & Clinical: 
    • SAR6500984:  A New "Blockbuster" Drug For Myeloma
    • Black Swan Research Initiative® (BSRI®) Debut of a Highly Sensitive MRD Test
    • Meet the Researchers
      • Roman Hájek, MD, PhD
      • Manoj Pandey, PhD
  • Nurse Leadership Board 
    • Hematopoietic Stem Cell Transplantation and Multiple Myeloma
  • Supportive Care
    • Multiple Myeloma and the Hevylite® Assays
  • Education & Awareness
    • Federal Policy Update
    • As The Bill Turns: State Policy Update
    • Advocates Secure Legislator Support
  • Member Events:
    • Stolper Strong
    • Dance For A Cure
  • Staff Updates:
    • New IMF Team Members
  • Patient Experience
    • Life is Good and Misery is Optional: A Conversation with Kenton Hofmeister
  • 2014 IMF Calendar of Events

 related articles
Read Myeloma Today
Subscribe to Myeloma Today


You might also be interested in:

Read Myeloma Today
Issues of Myeloma Today are available in PDF form to read and download.

Subscribe to Myeloma Today